Our findings demonstrate the utility of our protocol for the isolation of iMyoblasts from iPSCs from healthy control (Ctrl) subjects and patients with FSHD1, LGMDR7, WWS, and LGMDR9 muscular dystrophies that express the molecular pathologies of these diseases. This evidence concerns the gene TCAP and muscular dystrophy.